In a report released today, Stephanie Davis from Barclays maintained a Sell rating on WW International (WW – Research Report), with a price target of $1.50. The company’s shares closed yesterday at $1.59.
According to TipRanks, Davis is an analyst with an average return of -6.8% and a 39.93% success rate. Davis covers the Healthcare sector, focusing on stocks such as Laboratory, Quest Diagnostics, and Healthequity.
Currently, the analyst consensus on WW International is a Moderate Buy with an average price target of $5.75.
WW market cap is currently $136.2M and has a P/E ratio of -1.07.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
WW International (WW) Company Description:
WW International, Inc. engages in the provision of weight management services. It operates through the following geographical segments: North America, United Kingdom, Continental Europe and Other. The North America segment consists of United States and Canada Company-owned operations. The United Kingdom segment includes United Kingdom Company-owned operations. The Continental Europe segment comprises of Germany, Switzerland, France, Spain, Belgium, Netherlands, and Sweden Company-owned operations. The others segment offers Australia, New Zealand, Mexico, and Brazil Company-owned operations, as well as revenues and costs from franchises in the United States. The company was founded by Jean Nidetch in 1963 and is headquartered in New York, NY.
